skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Prevalence, incidence and persistence of ADHD drug use in Japan

Epidemiology and psychiatric sciences, 2019-12, Vol.28 (6), p.692-696 [Peer Reviewed Journal]

Copyright © Cambridge University Press 2018. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content ;ISSN: 2045-7960 ;EISSN: 2045-7979 ;DOI: 10.1017/S2045796018000252

Full text available

Citations Cited by
  • Title:
    Prevalence, incidence and persistence of ADHD drug use in Japan
  • Author: Okumura, Y ; Usami, M ; Okada, T ; Saito, T ; Negoro, H ; Tsujii, N ; Fujita, J ; Iida, J
  • Subjects: Age groups ; Attention deficit hyperactivity disorder ; Drug dosages ; Drug use ; Health insurance ; Hyperactivity ; Patients ; Population ; Prescription drugs ; Teenagers
  • Is Part Of: Epidemiology and psychiatric sciences, 2019-12, Vol.28 (6), p.692-696
  • Description: [...]little is known about ADHD drug use in the Japanese population. [...]we aimed to estimate the prevalence, incidence and persistence of ADHD drug use in children and adolescents in Japan. [...]we excluded those who had a bundled payment claim within 180 days before and after the index date, in which the prescription status was not recorded. [...]we excluded those who had a prescription of ADHD drugs within 180 days before the index date. Sample characteristics of patients Prevalent user (N = 86 756) Incident user (N = 30 449) Characteristic N % n % Provider type Clinic 41 500 47.8 15 055 49.4 Hospital 45 256 52.2 15 394 50.6 Setting Inpatient 508 0.6 220 0.7 Ambulatory 86 248 99.4 30 229 99.3 Prescriber Non-psychiatrist 46 157 53.2 15 239 50.0 Psychiatrist 40 599 46.8 15 210 50.0 Sex Boys 72 520 83.6 24 528 80.6 Girls 14 236 16.4 5921 19.4 Age, years 0–6 2659 3.1 2382 7.8 7–12 52 626 60.7 19 494 64.0 13–15 22 265 25.7 6051 19.9 16–18 9206 10.6 2522 8.3 Individual ADHD drugs ATX 31 491 36.3 12 876 42.3 OROS-MPH 51 013 58.8 17 384 57.1 Both 4252 4.9 189 0.6 ADHD, attention-deficit/hyperactivity disorder; ATX, atomoxetine; OROS-MPH, osmotic-controlled release oral delivery system methylphenidate.
  • Publisher: Verona: Cambridge University Press
  • Language: English;Italian
  • Identifier: ISSN: 2045-7960
    EISSN: 2045-7979
    DOI: 10.1017/S2045796018000252
  • Source: ProQuest One Psychology
    Journals@Ovid Open Access Journal Collection Rolling
    PubMed Central
    ProQuest Central

Searching Remote Databases, Please Wait